期刊
HELIYON
卷 9, 期 11, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.heliyon.2023.e21544
关键词
Osteoarthritis; Drug delivery; Biomedicine; Biomaterials; Regeneration
Polymeric biomaterials have great potential for drug delivery systems (DDS) in the field of osteoarthritis (OA) therapy. This review summarizes recent advances in polymeric DDS for OA therapy, including an overview of OA pathophysiology, different categories of polymeric DDS, and the delivery of bioactive agents. Prospective directions for advancing polymeric DDS are also highlighted.
Polymeric biomaterials have emerged as a highly promising candidate for drug delivery systems (DDS), exhibiting significant potential to enhance the therapeutic landscape of osteoarthritis (OA) therapy. Their remarkable capacity to manifest desirable physicochemical attributes, coupled with their excellent biocompatibility and biodegradability, has greatly expanded their utility in pharmacotherapeutic applications. Nevertheless, an urgent necessity exists for a comprehensive synthesis of the most recent advances in polymeric DDS, providing valuable guidance for their implementation in the context of OA therapy. This review is dedicated to summarizing and examining recent developments in the utilization of polymeric DDS for OA therapy. Initially, we present an overview of the intricate pathophysiology characterizing OA and underscore the prevailing limitations inherent to current treatment modalities. Subsequently, we introduce diverse categories of polymeric DDS, including hydrogels, nanofibers, and microspheres, elucidating their inherent advantages and limitations. Moreover, we discuss and summarize the delivery of bioactive agents through polymeric biomaterials for OA therapy, emphasizing key findings and emerging trends. Finally, we highlight prospective directions for advancing polymeric DDS, offering a promising approach to enhance their translational potential for OA therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据